ReviewFrontiers in psychiatry2024
Premenstrual syndrome: new insights into etiology and review of treatment methods.
Review in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Contemplative-based interventions for premenstrual syndrome: a systematic review of psychobiological outcomes.Frontiers in psychology · 2026Pooled it
- Effectiveness of symptom map-based education in the management of premenstrual syndrome: a randomized controlled trial.Archives of women's mental health · 2026Trial
- Premenstrual Disorders in Adolescents: An Interdisciplinary Perspective.Journal of clinical medicine · 2026Review
- Article
- Self-Reported Changes in Premenstrual and Menstrual Symptoms among Females Taking a Novel Multinutrient Supplement: A Pilot Study.Current developments in nutrition · 2026Article
- Prevalence of Premenstrual Syndrome and Its Impact on Productivity Among Young Female Medical Students.Cureus · 2026Article
- Structural equation modeling of the effect of childhood trauma on premenstrual syndrome: the mediating role of rumination in adolescent girls.Scientific reports · 2026Article
- Hormonal Imbalance and Gut Dysbiosis: Emerging Perspectives in Women's Health.Probiotics and antimicrobial proteins · 2026Review
- The interplay between premenstrual syndrome, eating disorder risk, and adiposity indicators: a cross-sectional study.BMC women's health · 2026Article
- Chemotherapy-induced estradiol reduction is associated with less relief of pre-chemotherapy anxiety in breast cancer patients.Psychoneuroendocrinology · 2026Article
- Article
- Premenstrual Syndrome and Nutritional Factors: A Narrative Review of Current Evidence and Clinical Implications.Journal of clinical medicine · 2026Review
- How does premenstrual syndrome affect occupational performance?BMC women's health · 2026Article
- Premenstrual syndrome-related quality of life: associations with ultra-processed food consumption, mindful eating, well-being, and social media addiction in women.BMC women's health · 2026Article
- Effect of Targeted Yoga Practice on PMS Symptoms, Body Composition, and Hip Mobility: An Eight-Week Pilot Study.Sports (Basel, Switzerland) · 2026Article
- Review
- Bedtime Procrastination and Attention as Serial Mediators Between Premenstrual Syndrome and Test Anxiety in Nursing College Students: A Multicenter Cross-Sectional Study.Psychology research and behavior management · 2026Article
- Observational
- Article
- Premenstrual Disorders, Their Severity Patterns, and Predictors Among Female University Students in Western Uganda: A Cross-Sectional Study.Health science reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Premenstrual syndrome (PMS) is a common disorder affecting women of reproductive age, with an estimated global prevalence of 47.8%, with severe symptoms occurring in 3-8%, significantly affecting daily functioning. GABA conductance and changes in neurosteroid levels, particularly allopregnanolone, are suspected to play a substantial role in the disorder's etiology. In this paper, we provide an overview of recent reports on the etiology and recognized therapeutic approaches, encompassing both pharmacological and non-pharmacological interventions. Our examination includes studies on SSRIs, hormonal agents, neurosteroids, supplementation, and therapeutic roles. We aim to determine the most favorable treatment regimen by comparing medication effects and alternative methods. The treatment of PMS is crucial for enhancing the quality of life for affected women. Medications used in PMS treatment should be individually selected to achieve the best therapeutic effect, considering the clinical situation of the patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.